Published in J Virol on March 01, 1993
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J Virol (1994) 2.21
Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol (1999) 1.86
Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses (2012) 1.55
Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J Virol (2004) 1.32
The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain. J Virol (2003) 1.26
Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol (2009) 1.18
The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J Virol (1995) 1.17
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature (2016) 1.12
Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol (1999) 1.02
Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol (1999) 0.97
Characterization of murine coronavirus neutralization epitopes with phage-displayed peptides. Virology (2000) 0.85
Simultaneous detection of antibodies to mouse hepatitis virus recombinant structural proteins by a microsphere-based multiplex fluorescence immunoassay. Clin Vaccine Immunol (2011) 0.75
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol (1990) 61.47
A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem (1982) 15.84
Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci U S A (1991) 3.70
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31
The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol (1982) 3.12
Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion. Virology (1982) 2.94
Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology (1984) 2.57
Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J Virol (1985) 2.38
Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol (1986) 2.35
Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol (1990) 2.21
Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology (1987) 2.16
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J Mol Biol (1987) 2.07
Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology (1989) 1.79
Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology (1984) 1.69
Assembly of coronavirus spike protein into trimers and its role in epitope expression. J Virol (1990) 1.60
Western and dot immunoblotting analysis of viral antigens and antibodies: application to murine hepatitis virus. J Immunol Methods (1984) 1.58
Random nature of coronavirus RNA recombination in the absence of selection pressure. Virology (1991) 1.57
Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J Virol (1990) 1.55
Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2). J Gen Virol (1984) 1.36
Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM. J Gen Virol (1987) 1.32
Coronavirus IBV: structural characterization of the spike protein. J Gen Virol (1983) 1.25
Recommendations of the Coronavirus Study Group for the nomenclature of the structural proteins, mRNAs, and genes of coronaviruses. Virology (1990) 1.21
Characterization of the structural proteins of the murine coronavirus strain A59 using monoclonal antibodies. Proc Soc Exp Biol Med (1987) 1.16
Amino acid sequence of a conserved neutralizing epitope of murine coronaviruses. J Virol (1989) 1.15
The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. J Gen Virol (1988) 1.10
Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology (1992) 1.08
Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies. J Virol (1991) 1.07
Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J Virol (1990) 1.05
Antigenic variation among murine coronaviruses: evidence for polymorphism on the peplomer glycoprotein, E2. Virus Res (1985) 1.04
Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59. Virology (1990) 1.00
Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk. J Virol (1988) 0.88
Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoprotein. Virus Res (1991) 0.84
Antiidiotypic vaccination against murine coronavirus infection. J Immunol (1991) 0.84
Physico-chemical properties of murine hepatitis virus, strain A 59. Brief report. Arch Virol (1987) 0.81
The use of ELISA for detection of the antibody-induced conformational change in a viral protein and its intermolecular spread. J Virol Methods (1990) 0.78
Localization of antigenic sites on the surface glycoprotein of mouse hepatitis virus. J Gen Virol (1991) 0.77
Association of depression and diabetes complications: a meta-analysis. Psychosom Med (2001) 8.30
NHS-wide networking and patient confidentiality. BMJ (1995) 7.38
The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol (1980) 6.24
Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59). Virology (1981) 4.01
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63
Pneumococcal vaccine campaign based in general practice. BMJ (1997) 3.50
A reproducible microanalytical method for the detection of specific RNA sequences by dot-blot hybridization. Anal Biochem (1984) 3.47
Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily. J Virol (1991) 3.35
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31
Why do symptomatic patients delay obtaining care for tuberculosis? Am J Respir Crit Care Med (1998) 3.30
Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology (1981) 3.26
Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science (1998) 3.19
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clin Proc (2001) 3.17
Black-white mortality differences by family income. Lancet (1992) 3.15
The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol (1982) 3.12
The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc Natl Acad Sci U S A (1999) 3.06
Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion. Virology (1982) 2.94
Coronavirus spike proteins in viral entry and pathogenesis. Virology (2001) 2.85
Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology (1988) 2.83
Genomic RNA of the murine coronavirus JHM. J Gen Virol (1978) 2.78
The primary structure and expression of the second open reading frame of the polymerase gene of the coronavirus MHV-A59; a highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism. Nucleic Acids Res (1990) 2.71
Translation of three mouse hepatitis virus strain A59 subgenomic RNAs in Xenopus laevis oocytes. J Virol (1981) 2.69
Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology (1989) 2.69
Synthesis of subgenomic mRNA's of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping. J Virol (1981) 2.65
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology (2009) 2.58
Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology (1984) 2.57
Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology (1987) 2.53
Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. J Virol (1999) 2.49
Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax (1996) 2.46
Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences. Proc Natl Acad Sci U S A (1999) 2.42
Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37
Coronavirus JHM: cell-free synthesis of structural protein p60. J Virol (1980) 2.37
Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol (1986) 2.35
Prevalence and diagnosis of chronic respiratory symptoms in adults. BMJ (1989) 2.28
Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol (1990) 2.21
Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker. J Biol Chem (2001) 2.18
Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J Virol (1991) 2.16
Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology (1987) 2.16
The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology (1996) 2.15
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood (1994) 2.14
An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proc Natl Acad Sci U S A (1997) 2.11
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol (1989) 2.08
Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J Mol Biol (1987) 2.07
Age-related changes underlie switch in netrin-1 responsiveness as growth cones advance along visual pathway. Nat Neurosci (2002) 2.06
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem (1994) 2.06
Ty1-copia group retrotransposons are ubiquitous and heterogeneous in higher plants. Nucleic Acids Res (1992) 2.05
Coronavirus JHM: intracellular protein synthesis. J Gen Virol (1981) 2.05
Chlamydia trachomatis, infertility, and population growth in sub-Saharan Africa. Sex Transm Dis (1993) 2.05
A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol (2000) 2.04
Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol (1998) 2.04
The biology of coronaviruses. J Gen Virol (1983) 2.03
Proteolytic processing of the replicase ORF1a protein of equine arteritis virus. J Virol (1994) 2.03
[Acyclovir freely obtainable]. Ned Tijdschr Geneeskd (1996) 2.03
AIDS, HIV and the Sunday Times. Nature (1994) 2.02
Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00
Protein structure of lymphocytic choriomeningitis virus: evidence for a cell-associated precursor of the virion glycopeptides. Virology (1979) 2.00
Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res (1993) 1.95
An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis (1976) 1.95
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol (1986) 1.95
Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol (1997) 1.93
The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol (2000) 1.91
Cancer screening guidelines. Am Fam Physician (2001) 1.89
Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse (1999) 1.88
Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins. J Virol (1987) 1.87
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res (2000) 1.86
Ethnic differences in stroke mortality between non-Hispanic whites, Hispanic whites, and blacks. The National Longitudinal Mortality Study. Stroke (1994) 1.85
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol (1998) 1.83
Evaluation of social status as a contributing factor to the stroke belt region of the United States. Stroke (1997) 1.81
The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol (2001) 1.80
Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology (1989) 1.79
Sequence relationships between the genome and the intracellular RNA species 1, 3, 6, and 7 of mouse hepatitis virus strain A59. J Virol (1982) 1.78
Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Qual Life Res (1993) 1.78
Proinflammatory interactions of pyocyanin and 1-hydroxyphenazine with human neutrophils in vitro. J Infect Dis (1990) 1.77
The influence of downstream protein-coding sequence on internal ribosome entry on hepatitis C virus and other flavivirus RNAs. RNA (2001) 1.77
Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy (1997) 1.76
In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils. J Immunol (1976) 1.76
Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol (1991) 1.75
Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant (2000) 1.75
Mineralogy of a mudstone at Yellowknife Bay, Gale crater, Mars. Science (2013) 1.75
Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesis. EMBO J (2001) 1.75
The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2. J Virol (1985) 1.74
Sonic hedgehog is required for cardiac outflow tract and neural crest cell development. Dev Biol (2005) 1.74
All subgenomic mRNAs of equine arteritis virus contain a common leader sequence. Nucleic Acids Res (1990) 1.74
Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature (1982) 1.73
The association between prenatal care and birth weight among women exposed to cocaine in New York City. JAMA (1993) 1.72
The arterivirus replicase is the only viral protein required for genome replication and subgenomic mRNA transcription. J Gen Virol (2000) 1.72
Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology (1986) 1.71
Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses. Virology (1988) 1.70
Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike. Virology (1994) 1.70
Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology (1984) 1.69
The carboxyl-terminal part of the putative Berne virus polymerase is expressed by ribosomal frameshifting and contains sequence motifs which indicate that toro- and coronaviruses are evolutionarily related. Nucleic Acids Res (1990) 1.68
Protein-protein interactions in lymphocytic choriomeningitis virus. Virology (1991) 1.68